间歇性人体成分分析作为重症COVID-19患者肌肉消耗监测工具
该研究对54例重症COVID-19患者进行人体成分分析,住院期间至少3次测量、共239次评估,用线性混合模型分析腰大肌面积(PMA)和总腹部肌肉面积(TAMA)变化,并用Cox回归分析其与生存的关系。结果显示,非幸存者长期PMA丢失率2.62%/天(vs 幸存者1.16%/天,p<0.001)、最大肌肉衰减5.48%/天(vs 3.66%/天,p=0.039)均显著更高。ROC分析显示住院期间平均PMA丢失的判别力最强(AUC=0.777),日均PMA下降1.84%被定义为阈值,超过该阈值的肌肉丢失是死亡的显著预测因子。作者认为,基于临床指征CT的间歇性人体成分分析是有价值的监测工具,有助于识别不良结局高危个体并支持重症决策。
要点
- 非幸存者长期PMA丢失率为2.62%/天,显著高于幸存者的1.16%/天(p<0.001)。
- 非幸存者最大肌肉衰减为5.48%/天,显著高于幸存者的3.66%/天(p=0.039)。
- 首次可获得的衰减率在生存组间无显著差异,但在Cox回归中与生存显著相关(p=0.011)。
- 住院期间平均PMA丢失对生存的判别力最强(AUC=0.777),日均下降1.84%被定义为阈值。
- 超过日均PMA下降1.84%阈值的肌肉丢失是人体成分分析衍生的显著死亡预测因子。
适用人群与场景
- 重症COVID-19患者,共54例,住院期间至少进行3次人体成分分析测量,总计239次评估。
诊断标准与关键阈值
- 采用ROC分析和约登指数定义日均PMA下降1.84%为肌肉衰减阈值。
研究设计与关键结果
- 研究类型为对54例重症COVID-19患者进行的间歇性人体成分分析监测研究,住院期间至少3次测量、共239次评估,用线性混合模型分析PMA和TAMA变化。
- 非幸存者长期PMA丢失率为2.62%/天,幸存者为1.16%/天,差异显著(p<0.001)。
- 非幸存者最大肌肉衰减为5.48%/天,幸存者为3.66%/天,差异显著(p=0.039)。
- 首次可获得的衰减率在生存组间无显著差异,但在Cox回归中与生存显著相关(p=0.011)。
- ROC分析显示,住院期间平均PMA丢失对生存的判别力最强(AUC=0.777)。
- 日均PMA下降1.84%被定义为阈值,超过该阈值的肌肉丢失是人体成分分析衍生的显著死亡预测因子。
证据类型、等级与局限
- 证据类型:基于临床指征CT的间歇性人体成分分析监测研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于临床指征CT的间歇性人体成分分析是有价值的监测工具,可识别不良结局高危个体,并具有支持重症决策的很大潜力。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: SARS-CoV-2 virus infection can lead to acute respiratory distress syndrome (ARDS), which can be complicated by severe muscle wasting. Until now, data on muscle loss of critically ill COVID-19 patients are limited, while computed tomography (CT) scans for clinical follow-up are available. We sought to investigate the parameters of muscle wasting in these patients by being the first to test the clinical application of body composition analysis (BCA) as an intermittent monitoring tool.
MATERIALS: BCA was conducted on 54 patients, with a minimum of three measurements taken during hospitalization, totaling 239 assessments. Changes in psoas- (PMA) and total abdominal muscle area (TAMA) were assessed by linear mixed model analysis. PMA was calculated as relative muscle loss per day for the entire monitoring period, as well as for the interval between each consecutive scan. Cox regression was applied to analyze associations with survival. Receiver operating characteristic (ROC) analysis and Youden index were used to define a decay cut-off.
RESULTS: Intermittent BCA revealed significantly higher long-term PMA loss rates of 2.62% (vs. 1.16%, p < 0.001) and maximum muscle decay of 5.48% (vs. 3.66%, p = 0.039) per day in non-survivors. The first available decay rate did not significantly differ between survival groups but showed significant associations with survival in Cox regression (p = 0.011). In ROC analysis, PMA loss averaged over the stay had the greatest discriminatory power (AUC = 0.777) for survival. A long-term PMA decline per day of 1.84% was defined as a threshold; muscle loss beyond this cut-off proved to be a significant BCA-derived predictor of mortality.
CONCLUSION: Muscle wasting in critically ill COVID-19 patients is severe and correlates with survival. Intermittent BCA derived from clinically indicated CT scans proved to be a valuable monitoring tool, which allows identification of individuals at risk for adverse outcomes and has great potential to support critical care decision-making.
参考来源
- Kolck J, Rako ZA, Beetz NL, et al. Intermittent body composition analysis as monitoring tool for muscle wasting in critically ill COVID-19 patients. Ann Intensive Care. 2023. PMID: 37421448. doi:10.1186/s13613-023-01162-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。